How to choose an appropriate probiotic: a guide for clinicians | CMAC

How to choose an appropriate probiotic: a guide for clinicians

Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(2):172-180

​ Andreeva I.V., Belmer S.V., Dovgan E.V., Novikova V.P., Selimzyanova L.R., Stetsiouk O.U., Surkov A.N.
10.36488/cmac.2025.2.172-180
probiotic probiotic microorganisms Lactobacillus Bifidobacterium
Section
Antimicrobials
Type
Review
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2025; 27(2):172-180

Abstract

The annual increase in probiotic usage is nothing short of phenomenal. Given the large volume of information on beneficial microorganisms, it can be challenging for clinicians to select the most suitable probiotic for a patient. This article provides specific advice on probiotic selection for physicians, considering the evidence base of specific strains and situation in pharmaceutical market in Russia.

Irina V. Andreeva

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

Belmer S.V.

N.I. Pirogov Russian National Research Medical University, Moscow, Russia

Eugeniy V. Dovgan

Smolensk Regional Clinical Hospital, Smolensk, Russia

Novikova V.P.

Saint Petersburg State Pediatric Medical University, Saint Petersburg, Russia

Selimzyanova L.R.

Research Institute of Pediatrics and Children's Health at the NCC

Olga U. Stetsiouk

Institute of Antimicrobial Chemotherapy, Smolensk, Russia

Surkov A.N.

Research Institute of Pediatrics and Children's Health at the NCC

  • 1. Schultz M., Baranchi A., Thurston L., Yu Y.C., Wang L., Chen J., et al. Consumer demographics and expectations of probiotic therapy in New Zealand: results of a large telephone survey. N Z Med J. 2011;124(1329):36-43. PMID: 21475358.
  • 2. Clarke T.C., Black L.I., Stussman B.J., Barnes P.M., Nahin R.L. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl Health Stat Report. 2015;(79):1-16. PMID: 25671660.
  • 3. Draper K., Ley C., Parsonnet J. A survey of probiotic use practices among patients at a tertiary medical centre. Benef Microbes. 2017;8(3):345-351. DOI: 10.3920/BM2016.0148
  • 4. Sniffen J.C., McFarland L.V., Evans C.T., Goldstein E.J.C. Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. PLoS One. 2018;13(12):e0209205. DOI: 10.1371/journal.pone.0209205
  • 5. Kaibysheva V.O., Nikonov E.L. Probiotics from the standpoint of evidence-based medicine. Russian journal of evidence-based gastroenterology. 2019;8(3):45-54. Russian. DOI: 10.17116/dokgastro2019803145
  • 6. Grand View Research. Nutraceuticals and Functional Foods. Global Industry Report. September 2016. Available at: www.grandviewresearch.com/industry-analysis/probiotics-market. Accessed June 30, 2025.
  • 7. Probiotics Market Report Scope & Overview. Available at: www.snsinsider.com/reports/probiotics-market-1357. Accessed June 30, 2025.
  • 8. Probiotics Market Size, Share, and Growth Analysis, By Product Type (Functional Food & Beverages, Dietary Supplements), By Ingredient (Bacteria, Yeast), By Distribution Channel, By End User, By Region – Industry Forecast 2025-2032. Available at: www.giiresearch.com/report/sky1701128-probiotics-market-size-share-growthanalysis-by.html. Accessed June 30, 2025.
  • 9. McFarland L.V. From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis. 2015;60(Suppl. 2):S85-90. DOI: 10.1093/cid/civ054
  • 10. Higashikawa F., Noda M., Awaya T., Danshiitsoodol N., Matoba Y., Kumagai T., et al. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial. Eur J Clin Nutr. 2016;70(5):582-587. DOI: 10.1038/ejcn.2016.17
  • 11. Andreeva I.V., Tolpygo A.V., Andreev V.A., Azizov I.S., Golman I.A., Osipova N.N., et al. Psychobiotics: a new way in psychopharmacology, or how do bacteria manage our brain? Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2022;24(2):108-133. Russian. DOI: 10.36488/cmac.2022.2.108-133
  • 12. Stetsiouk O.U., Andreeva I.V. The evidence base and practical approaches to probiotic use in clinical practice: a focus on Lactobacillus rhamnosus GG and Bifidobacterium lactis Вb-12. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2019;21(2):100-118. Russian. DOI: 10.36488/cmac.2019.2.100-118
  • 13. Andreev V.A., Stetsiouk O.U., Andreeva I.V. Probiotics: controversial issues. Kliniceskaa mikrobiologia i antimikrobnaa himioterapia. 2022;24(4):345-360. Russian. DOI: 10.36488/cmac.2022.4.345-360
  • 14. Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502. DOI: 10.1038/nrgastro.2017.75
  • 15. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-614. DOI: 10.1038/nrgastro.2014.66
  • 16. Wilkins T., Sequoia J. Probiotics for gastrointestinal conditions: a summary of the evidence. Am Fam Physician. 2017;96(3):170-178. PMID: 28762696.
  • 17. Ouwehand A.C., Invernici M.M., Furlaneto F.A.C., Messora M.R. Effectiveness of multistrain versus singlestrain probiotics: current status and recommendations for the future. J Clin Gastroenterol. 2018;52(Suppl. 1). Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, Rome, Italy, September 10-12, 2017:S35-S40. DOI: 10.1097/MCG.0000000000001052
  • 18. Miller L.E., Zimmermann A.K., Ouwehand A.C. Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit. World J Gastroenterol. 2016;22(21):5122-5131. DOI: 10.3748/wjg.v22.i21.5122
  • 19. Laterza L., Gibiino G., Scaldaferri F., Gasbarrini A. Benefits of multistrain bacteria formulations for health. J Func Foods. 2018;47:531-546. DOI: 10.1016/j.jff.2018.05.051
  • 20. Zeng Y., He P., Lyu C., Wu Y., Xinyu Zhao X., Gu Q., et al. Constipation targeted monostrain and multispecies probiotics: effects on symptoms and gut microbiota. Food Science and Human Wellness. 2026(15). DOI: 10.26599/FSHW.2025.9250509
  • 21. Timmerman H.M., Koning C.J., Mulder L., Rombouts F.M., Beynen A.C. Monostrain, multistrain and multispecies probiotics – a comparison of functionality and efficacy. Int J Food Microbiol. 2004;96(3):219-233. DOI: 10.1016/j.ijfoodmicro.2004.05.012
  • 22. Collado M.C., Jalonen L., Meriluoto J., Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pac J Clin Nutr. 2006;15(4):570-575. PMID: 17077078.
  • 23. Ouwehand A.C., Isolauri E., Kirjavainen P.V., Tölkko S., Salminen S.J. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Lett Appl Microbiol. 2000;30(1):10-13. DOI: 10.1046/j.1472-765x.2000.00590.x
  • 24. Martins F.S., Silva A.A., Vieira A.T., Barbosa F.H., Arantes R.M., Teixeira M.M., et al. Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol. 2009;191(8):623-630. DOI: 10.1007/s00203-009-0491-x
  • 25. Tabasco R., García-Cayuela T., Peláez C., Requena T. Lactobacillus acidophilus La-5 increases lactacin B production when it senses live target bacteria. Int J Food Microbiol. 2009;132(2-3):109-116. DOI: 10.1016/j.ijfoodmicro.2009.04.004
  • 26. Kekkonen R. Immunomodulatory effects of probiotic bacteria in healthy adults. Academic Dissertation. Helsinki. 2008. 122 p.
  • 27. WGO Practice Guideline. Probiotics and prebiotics. World Gastroenterology Organization. 2023. Available at: www.worldgastroenterology.org/guidelines/probioticsand-prebiotics. Accessed June 30, 2025.
  • 28. Federal Law №150-FZ of June 7, 2025, on Amendments to Certain Legislative Acts of the Russian Federation. Russian. Available at: www.kremlin.ru/acts/bank/51994. Accessed June 30, 2025. Russian.
  • 29. Lobzin Yu.V., Uskov A.N., Behtereva M.K., Komarova A.M., Rychkova S.V., Mazankova L.N., et al. Rotavirus gastroenteritis in children. (ID 755_1), 2023, 45 p. Available at: https://cr.minzdrav.gov.ru/preview-cr/755_1. Accessed June 30, 2025. Russian.
  • 30. Lobzin Yu.V., Zhdanov K.V., Uskov A.N., Behtereva M.K., Rychkova S.V., Zakharenko S.M. Norovirus gastroenteritis in children (ID 825_1), 2024, 34 p. Available at: https://cr.minzdrav.gov.ru/view-cr/825_1. Accessed June 30, 2025. Russian.
  • 31. Abdoulkhakov R.A., Abdoulkhakov S.R., Alekseeva O.P., Alekseenko S.A., Andreev D.N., Baranovsky A.Yu., et al. Gastritis and duodenitis (ID 708_2), 2024, 69 p. Available at: https://cr.minzdrav.gov.ru/preview-cr/708_2. Accessed June 30, 2025. Russian.
  • 32. Novikova V.P., Baryshnikova N.V., Khavkin A.I., Gurova M.M., Kalinina E.Yu., Zavyalova A.N., et al. Gastritis and duodenitis in children. (ID 837_1), 2024, 88 p. Available at: https://cr.minzdrav.gov.ru/view-cr/837_1. Accessed June 30, 2025. Russian.
  • 33. Aleshin D.V., Achkasov S.I., Baranskaya E.K., Ivashkin V.T., Kulikova N.D., Lapina T.L., et al. Constipation. (274_3), 2024, 48 p. Available at: https://cr.minzdrav.gov.ru/preview-cr/274_3. Accessed June 30, 2025. Russian.
  • 34. Ivashkin V.T., Shelygin Yu.A., Baranov A.A., NamazovaBaranova L.S., Achkasov S.I., Alekseeva O.P., et al. Irritable bowel syndrome. (ID 892_1), 2024, 64 p. Available at: https://cr.minzdrav.gov.ru/preview-cr/892_1. Accessed June 30, 2025. Russian.
  • 35. Ivashkin V.T., Gorelov A.V., Abdulganieva D.I., Alekseeva O.P., Alekseenko S.A., Baranovsky A.Yu., et al. Methodological guidelines of the scientific Community for Human Microbiome Research (CHMR) and the Russian Gastroenterology Association (RGA) on the use of probiotics, prebiotics, synbiotics, metabiotics and functional foods enriched with them for the treatment and prevention of gastrointestinal diseases in adults and children. Russian journal of gastroenterology, hepatology, proctology. 2024;34(4):113-136. Russian. DOI: 10.22416/1382-4376-2024-117-312
  • 36. Ouwehand A.C. A review of dose-responses of probiotics in human studies. Benef Microbes. 2017;8(2):143-151. DOI: 10.3920/BM2016.0140
  • 37. Ouwehand A.C., Forssten S., Hibberd A.A., Lyra A., Stahl B. Probiotic approach to prevent antibiotic resistance. Ann Med. 2016;48(4):246-255. DOI: 10.3109/07853890.2016.1161232
  • 38. Guo Q., Goldenberg J.Z., Humphrey C., El Dib R., Johnston B.C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2019;4(4):CD004827. DOI: 10.1002/14651858.CD004827.pub5
  • 39. Kligler B., Cohrssen A. Probiotics. Am Fam Physician. 2008;78(9):1073-1078. PMID: 19007054.
  • 40. Stavropoulou E., Bezirtzoglou E. Probiotics in medicine: a long debate. Front Immunol. 2020;11:2192. DOI: 10.3389/fimmu.2020.02192
  • 41. Shewale R.N., Sawale P.D., Khedkar C., Singh A. Selection criteria for probiotics: a review. Int J Probiotics Prebiotics. 2014;9(1):17-22.
  • 42. Gorelov A.V., Gritsenko V.A., Ermolenko K.D., Migacheva N.B., Usenko D.V. Guidelines for healthcare providers on using of probiotics for the treatment and prevention of infectious diseases in children. St. Petersburg: IPO «EASID», 2025. 88 p. Russian.
  • 43. Banerjee S. Recommendation and limitation of probiotics supplements. Curr Trends Pharm Pharm Chem. 2021;3(3):19-22. DOI: 10.18231/j.ctppc.2021.006
  • 44. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H,. Timmerman H.M., et al. Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651-659. DOI: 10.1016/S0140-6736(08)60207-X
  • 45. Boyle R.J., Robins-Browne R.M., Tang M.L. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 2006;83(6):1256-1264; quiz 1446-1447. DOI: 10.1093/ajcn/83.6.1256
  • 46. Stadlbauer V. Immunosuppression and probiotics: are they effective and safe? Benef Microbes. 2015;6(6):823-828. DOI: 10.3920/BM2015.0065
  • 47. Millette M., Nguyen A., Amine K.M., Lacroix M. Gastrointestinal survival of bacteria in commercial probiotic products. Intern J Prob Preb. 2013;8(4):149-156.
  • 48. Davani-Davari D., Negahdaripour M., Karimzadeh I., Seifan M., Mohkam M., Masoumi S.J., et al. Prebiotics: definition, types, sources, mechanisms, and clinical applications. Foods. 2019;8(3):92. DOI: 10.3390/foods8030092
Views
0 Abstract
0 PDF
0 Crossref citations
Shared